Publishing research using ab86387? Please let us know so that we can cite the reference in this datasheet.
ab86387 has been referenced in 6 publications.
- Cetti E et al. Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells. Cancer Lett 442:362-372 (2019). PubMed: 30445205
- Cao L et al. Inflammatory cytokine-induced expression of MASTL is involved in hepatocarcinogenesis by regulating cell cycle progression. Oncol Lett 17:3163-3172 (2019). PubMed: 30867746
- Serpico AF et al. Wee1 Rather Than Plk1 Is Inhibited by AZD1775 at Therapeutically Relevant Concentrations. Cancers (Basel) 11:N/A (2019). PubMed: 31200459
- Anania M et al. Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening. Oncotarget 6:34629-48 (2015). WB . PubMed: 26431489
- Chen YL et al. ENSA expression correlates with attenuated tumor propagation in liver cancer. Biochem Biophys Res Commun 442:56-61 (2013). IP ; Human . PubMed: 24211627
- Potapova TA et al. Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Mol Biol Cell 22:1191-206 (2011). WB ; Human . PubMed: 21325631